Leap Therapeutics (LPTX) EBITDA (2013 - 2025)
Leap Therapeutics (LPTX) EBITDA from Mar 31, 2013 to Jun 30, 2025. The TTM Leap Therapeutics (LPTX) EBITDA is -$63M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Leap Therapeutics (LPTX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +0.72% |
| 3 Years TTM | +8.85% |
| 5 Years TTM | +16.73% |
| 10 Years TTM | +9.20% |
| All Time TTM | +14.11% |
Annual EBITDA change of Leap Therapeutics (LPTX)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$33M | -51.37% |
| 2024 | -$67M | -17.32% |
| 2023 | -$81M | +50.04% |
| 2022 | -$54M | +34.92% |
| 2021 | -$40M | +49.24% |
| 2020 | -$27M | -16.48% |
| 2019 | -$32M | +39.26% |
| 2018 | -$23M | -22.42% |
| 2017 | -$30M | +21.91% |
| 2016 | -$24M | +104.45% |
| 2015 | -$12M | -39.58% |
| 2014 | -$20M | +49.13% |
| 2013 | -$13M | +89.54% |
| 2012 | -$6.98M | N/A |